Mizuho Medy Co Ltd operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mizuho Medy Co Ltd with three other
pharmaceutical manufacturers in Asia:
Apex Biotechnology Corporation
sales of 1.80 billion Taiwanese Dollars [US$60.93 million]
of which 58%
was Test Strip),
BioSino Bio-technology and Science Inc
(295.13 million Chinese Renmimbi [US$46.88 million]
Kainos Laboratories, Inc.
(4.70 billion Japanese Yen [US$43.69 million]
of which 52%
was immunological business).